Join us for a conversation with a Diabetes Care and Education Specialist as she discusses new glucagon treatment options, including efficacy, usability, safety. Attendees will have an opportunity to ask questions about the information presented.
Jennifer Goldman, RPh, PharmD, CDE, BC-ADM, FCCP
Dr. Jennifer Goldman, has been practicing for 30 years and is currently Professor of Pharmacy Practice at MCPHS University where she teaches in the pharmacy and physician assistant programs. She received both her BS and Doctorate degrees in Pharmacy from MCPHS and completed a residency at the Boston VA Medical Center. She is board certified in advanced diabetes management and is a certified diabetes educator. She is a fellow of the American College of Clinical Pharmacists. Dr. Goldman has practiced in family and internal medicine with a focus in diabetes and cardiovascular disease since 1997. She is an academic preceptor for MCPHS PharmD candidates and post-graduate fellows. She has served on various statewide and national organizational committees and boards. Her research interests are in the area of diabetes, cardiovascular disease and the scholarship of teaching with multiple publications and invited presentations in these areas.
The speaker is presenting on behalf of Xeris Pharmaceuticals. Xeris has announced a limited-time $0 copay offering for commercially eligible patients effective now through May 31, 2020 as a response to the COVID-19 pandemic. To access a digital copay card, please visit www.gvokeglucagon.com/savings-and-support.
RSVP required by Monday, June 1 at: https://jdrf-ne.org/VirtualEducationJune2.
